Discover
COSM
Cosmos Health Inc.
0.20
1 x 0.18
1 x 0.19
bid
ask
+
0.02
9.15%
1 @ 07:43 AM
0.21 +0.01 (5.61%)
| Ytd | -59.52% | |
| 1y | -48.83% |
0.17
day range
0.21
0.16
52 week range
1.32
| Open | 0.18 | Prev Close | 0.18 | Low | 0.17 | High | 0.21 | Mkt Cap | 12.52M |
| Vol | 11.15M | Avg Vol | 6.37M | EPS | -0.66 | P/E | N/A | Forward P/E | -12.36 |
| Beta | 3.14 | Short Ratio | 2.56 | Inst. Own | 10.28% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 04-16 | 50-d Avg | 0.28 | 200-d Avg | 0.52 | 1yr Est | 3.00 |
Earning
| Date | For | Estimate | Reported | Surprise | surprise % |
|---|---|---|---|---|---|
| 2024-11-14 | 2024-09 | -0.11 | -0.45 | -0.34 | -309.09% |
| 2024-08-20 | 2024-03 | 0 | N/A | N/A | N/A |
| 2024-08-20 | 2024-06 | -0.14 | -0.09 | 0.05 | 35.71% |
| 2024-08-20 | 2024-06 | -0.14 | N/A | N/A | N/A |
| 2024-08-20 | 2024-03 | 0 | -0.04 | N/A | N/A |
| 2024-08-06 | 2023-12 | 0 | N/A | N/A | N/A |
Upgrade / Downgrade
| Date | Firm | Action | From | To |
|---|
Profile
Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names. The company serves wholesale distributors and other healthcare providers, such as clinics, government agencies, independent retail and specialty pharmacies and independent specialty distributors. It sells its products through independent wholesale distributors. Cosmos Health Inc. was incorporated in 2009 and is headquartered in Chicago, Illinois.
Insider Holder
| Date | Name | Relation | Quantity | Description |
|---|---|---|---|---|
| 2023-04-02 | ASLIDIS ANASTASIOS | Director | 20.20K | Stock Award(Grant) |
| 2023-04-02 | BARDAKIS NIKOLAOS | Chief Operating Officer | 10.00K | Stock Award(Grant) |
| 2023-04-02 | HOIDAS JOHN JAMES | Director | 5.00K | Stock Award(Grant) |
| 2023-04-02 | IGNATIADES PAVLOS | Officer | 5.00K | Stock Award(Grant) |
| 2024-02-15 | SIOKAS GRIGORIOS | Chief Executive Officer | 1.39M | Purchase |
| 2023-10-23 | TERZIS GEORGIOS | Chief Financial Officer | 152.46K | Stock Award(Grant) |
Institution Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2024-09-29 | Armistice Capital, LLC | 1.66M | 1.03M | 7.13% |
| 2024-09-29 | Blackrock Inc. | 267.80K | 165.50K | 1.15% |
| 2024-09-29 | Geode Capital Management, LLC | 149.73K | 92.53K | 0.64% |
| 2024-09-29 | Vanguard Group Inc | 134.83K | 83.33K | 0.58% |
| 2024-09-29 | UBS Group AG | 115.67K | 71.48K | 0.50% |
| 2024-09-29 | State Street Corporation | 24.74K | 15.29K | 0.11% |
Fund Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2024-09-29 | Vanguard Extended Market Index Fund | 134.83K | 83.33K | 0.58% |
| 2024-10-30 | Fidelity Extended Market Index Fund | 89.96K | 55.60K | 0.39% |
| 2024-10-30 | Fidelity Series Total Market Index Fund | 22.65K | 14.00K | 0.10% |
| 2024-10-30 | Fidelity Total Market Index Fund | 21.79K | 13.47K | 0.09% |
| 2024-10-30 | Fidelity NASDAQ Composite Index Fund | 4.51K | 2.79K | 0.02% |
Split
| Split | Date |
|---|---|
| 1 : 25 | 2022-12-16 |
| 1 : 10 | 2017-11-21 |
| 1 : 10 | 2017-11-20 |